Committee on Sanitary and Phytosanitary Measures
If applicable, name of local government involved:
Products covered (provide tariff item number(s) as specified in national schedules deposited with the WTO; ICS numbers should be provided in addition, where applicable): Caffeine and caffeine citrate as food additives in non-alcoholic carbonated water-based flavoured and sweetened beverages other than cola type beverages (ICS Codes: 67.160, 67.220)
Regions or countries likely to be affected, to the extent relevant or practicable:
Title of the notified document: Interim Marketing Authorization regarding the use of caffeine and caffeine citrate as food additives in non-alcoholic carbonated water-based flavoured and sweetened beverages other than cola type beverages Language: English and French Number of pages: 2
Description of content: Health Canada has received a submission to permit the use of caffeine and caffeine citrate as food additives in non-alcoholic carbonated water-based flavoured and sweetened beverages other than cola type beverages. The maximum level of use of caffeine and caffeine citrate (calculated as caffeine), used singly or in combination in these beverages, would be 150 ppm in the finished product. This authorization is intended to provide for the addition of caffeine and caffeine citrate to the beverages commonly referred to as carbonated soft drinks, other than cola type soft drinks. This authorization does not change the provisions for the use of caffeine and caffeine citrate in cola type beverages, which will continue to be permitted at a maximum level of use of 200 ppm in the finished product.
Therefore, it is the intention of Health Canada to recommend that the Food and Drug Regulations be amended to permit the use of caffeine and caffeine citrate as food additives in non-alcoholic carbonated water-based flavoured and sweetened beverages other than cola type beverages at a maximum level of use of 150 ppm used singly or in combination in the finished product.
As a means to improve the responsiveness of the regulatory system, an Interim Marketing Authorization is being issued to permit the immediate use of caffeine and caffeine citrate, as indicated above, while the regulatory process is undertaken to amend the Regulations. The unstandardized foods described above are exempted from sections B.01.043 and B.16.007 of the Food and Drug Regulations.
The proposed regulatory amendments would be enabling measures to allow the sale of the beverages described above containing the food additives caffeine and caffeine citrate. The amendments are supported by the safety assessment and would have a low impact on the economy and on the environment. Consequently, the regulatory amendments may proceed directly to final approval and publication in the Canada Gazette, Part II.
Objective and rationale: [X] food safety, [ ] animal health, [ ] plant protection, [ ] protect humans from animal/plant pest or disease, [ ] protect territory from other damage from pests.
Is there a relevant international standard? If so, identify the standard:
Codex Alimentarius Commission (e.g. title or serial number of Codex standard or related text)
World Organization for Animal Health (OIE) (e.g. Terrestrial or Aquatic Animal Health Code, chapter number)
International Plant Protection Convention (e.g. ISPM number)
Does this proposed regulation conform to the relevant international standard?
If no, describe, whenever possible, how and why it deviates from the
Other relevant documents and language(s) in which these are available: Canada Gazette, Part I, 20 March 2010, Pages 452-453 (available in English and French)
Proposed date of adoption (dd/mm/yy): Immediate for this IMA. For the final regulation, normally within 12-18 months of publication of the Notice of Interim Marketing Authorization in the Canada Gazette, Part I, 20 March 2010.
Proposed date of publication (dd/mm/yy):
Proposed date of entry into force: [ ] Six months from date of publication, and/or (dd/mm/yy): Immediate for this IMA. For the final regulation, normally within 12-18 months of publication of the Notice of Interim Marketing Authorization in the Canada Gazette, Part I, 20 March 2010.
Final date for comments: [ ] Sixty days from the date of circulation of the notification and/or (dd/mm/yy): 3 June 2010
Agency or authority designated to handle comments: [ ] National Notification Authority, [X] National Enquiry Point. Address, fax number and e-mail address (if available) of other body:
Texts available from: [ ] National Notification Authority, [X] National Enquiry Point. Address, fax number and e-mail address (if available) of other body:
The electronic version of the regulatory text can be downloaded at: http://canadagazette.gc.ca/rp-pr/p1/2010/2010-03-20/pdf/g1-14412.pdf (Canada Gazette) or http://canadagazette.gc.ca/rp-pr/p1/2010/2010-03-20/html/notice-avis-eng.html#d106 (English) http://canadagazette.gc.ca/rp-pr/p1/2010/2010-03-20/html/notice-avis-fra.html#d106 (French)
LET’S TALK ABOUT IT: PREVENTING SEASICKNESS Ocean travelers need to take precautions to prevent motion sickness. In our experience, a small percentage of people get sick on any trip and most of these people are fine after a day or so at sea. If you feel that you are particularly susceptible to seasickness, it is a good idea to discuss it with your doctor prior to the trip. Having said that, I
Overview of Medications Glucophage –mild weight loss effect, works through the liver, and at the receptors, making your own insulin more effective. Eventually the pancreas may no longer produce enough insulin without assistance, and additional meds will be needed. Starlix – helps produce rise of insulin at meal times. Its advantage is that it works with food, producing ↑